BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (NVDL.PK) reported unaudited financial results for the six months ended June 30, 2012. As previously reported, if the Company cannot secure financing or a strategic partner, the Company may file for bankruptcy. The Company, at the end of March 2012, deregistered its common stock and exited the Securities and Exchange Commission reporting system. The Company recorded a loss of $24,000 or $(0.00) per share for the six months ended June 30, 2012, compared to a net loss of $7,597,000 or $(0.07) per share in the six months ended June 30, 2011.
